Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.b

Pneumonitis (ILD), acute and/or severe (may cause ARDS)

Publications

Carrillo-Esper R, Morales-Victorino N

[Imatinib-induced pulmonary toxicity].

Gaceta medica de Mexico 2009 Sep-Oct;145;437-9 — 2009 Sep-Oct — 437-9

Lin JT, Yeh KT, Fang HY, Chang CS

Fulminant, but reversible interstitial pneumonitis associated with imatinib mesylate.

Leukemia & lymphoma 2006 Aug;47;1693-5 — 2006 Aug — 1693-5